Home/Contractors/Health Decisions, INC.

Federal Contractor Profile

Health Decisions, INC.

Federal contracting record: $57M obligated across 21 awards from 1 agencies, FY 2016–2026.

$57M
Total Obligated
21
Award Records
1
Agencies Served
3
NAICS Codes
OverviewContractsAgenciesNAICS

Company Profile

UEI (Unique Entity Identifier)

CMKQYLSLNJG1

CAGE Code

3FAM0

Parent Organization

Health Decisions, INC.

Address

2510 MERIDIAN PKWY, DURHAM, NC, 277132260

First Federal Award

Nov 19, 2015

Most Recent Award

Apr 22, 2026

Federal Sales Analytics

Toggle between trend, agency drilldown, and treemap. Use the period selector to focus the time window.

Hover any bar for YoY change + award count. Current fiscal year shown at reduced opacity (partial year).

Top Federal Agencies

  • Department of Health and Human Services

    100.0% of total obligations

    $57M

Top NAICS Activity

  • 541712

    RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT BIOTECHNOLOGY)

    10 awards

    $37M

  • 541715

    RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY)

    10 awards

    $20M

  • 541710

    RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES

    1 awards

    $339K

Recent Federal Awards

DateAgencyNAICSDescriptionAmount
Apr 22, 2026Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NICHD541715STATISTICAL AND CLINICAL COORDINATING SERVICES FOR GROUPS C AND D OF CCN021 ENTITLED, "A STUDY TO EVALUATE THE PK AND PD OF IM OR SQ INJECTIONS OF LEVONORGESTREL BUTANOATE (LB) FOR FEMALE CONTRACEPTION"$297K
Apr 1, 2026Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NICHD541715FINALIZATION, PROCUREMENT OF REGULATORY APPROVAL, AND COMPLETE START-UP ACTIVITIES FOR THE OVAPRENE VAGINAL DEVICE CLINICAL TRIAL$27K
Feb 23, 2026Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NICHD541715NICHD: R&D: COORDINATION, MONITORING, FOLLOW-UP, EVALUATION, AND COMPLETION OF A CLINICAL TRIAL OF NESTORONE TESTOSTERONE GEL FOR MALE CONTRACEPTION: NON-SEVERABLE$358K
Sep 16, 2025Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NICHD541715TO AWARD TASK ORDER 75N94019F0025, INTERNAL NO. TASK ORDER 1 TITLE CORE FUNCTION ACTIVITIES FOR THE "NICHD CCTN STATISTICAL AND CLINICAL COORDINATING CENTER" SEPTEMBER 20, 2019 - SEPTEMBER 19, 2020.$487K
Jul 25, 2025Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NICHD541715NICHD: R&D: SUPPORTING THE PHASE IIB CLINICAL TRIAL OF SUBCUTANEOUS LEVONORGESTREL BUTANOATE (LB) FOR FEMALE CONTRACEPTION: NON-SEVERABLE$233K
May 21, 2025Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NICHD541715TO AWARD TASK ORDER 75N94019F0025, INTERNAL NO. TASK ORDER 1 TITLE CORE FUNCTION ACTIVITIES FOR THE "NICHD CCTN STATISTICAL AND CLINICAL COORDINATING CENTER" SEPTEMBER 20, 2019 - SEPTEMBER 19, 2020.$32K
Apr 30, 2025Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NICHD541715NICHD: R&D: COORDINATION, MONITORING, FOLLOW-UP, EVALUATION, AND COMPLETION OF A CLINICAL TRIAL OF NESTORONE TESTOSTERONE GEL FOR MALE CONTRACEPTION: NON-SEVERABLE$700K
Apr 21, 2025Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NICHD541715COORDINATION, MONITORING, FOLLOW-UP, AND EVALUATION OF A CLINICAL TRIAL OF NESTORONE TESTOSTERONE GEL FOR MALE CONTRACEPTION$70K
Apr 21, 2025Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NICHD541715STATISTICAL AND CLINICAL COORDINATING SERVICES FOR GROUPS C AND D OF CCN021 ENTITLED, "A STUDY TO EVALUATE THE PK AND PD OF IM OR SQ INJECTIONS OF LEVONORGESTREL BUTANOATE (LB) FOR FEMALE CONTRACEPTION"$607K
Dec 20, 2024Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NICHD541715COORDINATION, MONITORING, FOLLOW-UP, AND EVALUATION OF A CLINICAL TRIAL OF NESTORONE TESTOSTERONE GEL FOR MALE CONTRACEPTION$608K
Dec 20, 2024Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NICHD541715STATISTICAL AND CLINICAL COORDINATING SERVICES FOR GROUPS C AND D OF CCN021 ENTITLED, "A STUDY TO EVALUATE THE PK AND PD OF IM OR SQ INJECTIONS OF LEVONORGESTREL BUTANOATE (LB) FOR FEMALE CONTRACEPTION"$271K
Nov 27, 2024Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NICHD541715FINALIZATION, PROCUREMENT OF REGULATORY APPROVAL, AND COMPLETE START-UP ACTIVITIES FOR THE OVAPRENE VAGINAL DEVICE CLINICAL TRIAL$61K
Nov 14, 2024Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NICHD541715COORDINATION, MONITORING, FOLLOW-UP, AND EVALUATION OF A CLINICAL TRIAL OF NESTORONE TESTOSTERONE GEL FOR MALE CONTRACEPTION$24K
Sep 24, 2024Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NICHD541715ACQUISITION OF THE NESTORONE ESTRADIOL (NES/E2) VAGINAL RING$1.2M
Sep 20, 2024Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NICHD541715COORDINATION, MONITORING, FOLLOW-UP, AND EVALUATION OF A CLINICAL TRIAL OF NESTORONE TESTOSTERONE GEL FOR MALE CONTRACEPTION$783K
Sep 19, 2024Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NICHD541715PROTOCOL FINALIZATION, START-UP, COORDINATION, MONITORING, AND ALL OTHER ASSOCIATED ACTIVITIES FOR CLINICAL TRIALS EVALUATING PROGESTOGENIC ANDROGENS AS CONTRACEPTIVE AGENTS$994K
Sep 17, 2024Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NICHD541715TO AWARD TASK ORDER 75N94019F0025, INTERNAL NO. TASK ORDER 1 TITLE CORE FUNCTION ACTIVITIES FOR THE "NICHD CCTN STATISTICAL AND CLINICAL COORDINATING CENTER" SEPTEMBER 20, 2019 - SEPTEMBER 19, 2020.$18K
Aug 30, 2024Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NICHD541715FINALIZATION, PROCUREMENT OF REGULATORY APPROVAL, AND COMPLETE START-UP ACTIVITIES FOR THE OVAPRENE VAGINAL DEVICE CLINICAL TRIAL$457K
Aug 27, 2024Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NICHD541715TO AWARD TASK ORDER 75N94019F0025, INTERNAL NO. TASK ORDER 1 TITLE CORE FUNCTION ACTIVITIES FOR THE "NICHD CCTN STATISTICAL AND CLINICAL COORDINATING CENTER" SEPTEMBER 20, 2019 - SEPTEMBER 19, 2020.$479K
Aug 20, 2024Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NICHD541715TO AWARD TASK ORDER 75N94019F0025, INTERNAL NO. TASK ORDER 1 TITLE CORE FUNCTION ACTIVITIES FOR THE "NICHD CCTN STATISTICAL AND CLINICAL COORDINATING CENTER" SEPTEMBER 20, 2019 - SEPTEMBER 19, 2020.$44K
Aug 14, 2024Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NICHD541712IGF::OT::IGF EVALUATION OF THE PHARMACOKINETIC PROFILE, EFFECTS ON THE MECHANISMS OF CONTRACEPTIVE EFFICACY AND SAFETY OF MULTIPURPOSE PREVENTION TECHNOLOGIES PRODUCTS$432K
Jul 18, 2024Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NICHD541715FINALIZATION, PROCUREMENT OF REGULATORY APPROVAL, AND COMPLETE START-UP ACTIVITIES FOR THE OVAPRENE VAGINAL DEVICE CLINICAL TRIAL$173K
Apr 17, 2024Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NICHD541715STATISTICAL AND CLINICAL COORDINATING SERVICES FOR GROUPS C AND D OF CCN021 ENTITLED, "A STUDY TO EVALUATE THE PK AND PD OF IM OR SQ INJECTIONS OF LEVONORGESTREL BUTANOATE (LB) FOR FEMALE CONTRACEPTION"$492K
Mar 28, 2024Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NICHD541715TASK ORDER 2: STATUS DETERMINATION AND PRIORITIZATION OF PIPELINE PRODUCTS UNDERGOING CLINICAL TRIALS FOR MALE AND FEMALE CONTRACEPTION$249K
Feb 1, 2024Department of Health and Human ServicesNATIONAL INSTITUTES OF HEALTH NICHD541715STATISTICAL AND CLINICAL COORDINATING SERVICES FOR GROUPS C AND D OF CCN021 ENTITLED, "A STUDY TO EVALUATE THE PK AND PD OF IM OR SQ INJECTIONS OF LEVONORGESTREL BUTANOATE (LB) FOR FEMALE CONTRACEPTION"$127K

Related Contractors

Other companies active in NAICS 541712 — RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT BIOTECHNOLOGY).

Massachusetts Institute Of Technology

$4.4B

Brookhaven Science Associates LLC

$2.8B

Science Applications International Corporation

$2.3B

Torch Technologies INC

$1.6B

Odyssey Systems Consulting Group, LTD.

$1.2B

Aerojet Rocketdyne Of De, INC

$1.2B

Amentum Technology, INC.

$1.2B

Kbr Wyle Services, LLC

$1.1B

Track Health Decisions, INC. Recompetes Before They Post

Mindy monitors Health Decisions, INC.'s active contracts and alerts you 12 months before they expire — so you can position to compete on recompete.

Get Free Recompete Alerts